“invivodata was able to deliver us the real-time data that we needed to develop an unbiased view into our patients’ pain experiences. This kind of data cannot be collected with paper diaries.”
Dr. Michael Gendreau
Chief Medical Officer, Cypress Bioscience
Cenduit and invivodata Align to Integrate
- January 28, 2010
Cenduit and invivodata Align to Integrate
Clinical IRT and ePRO Solutions
Research Triangle Park, NC, USA – Cenduit, LLC, and invivodata, inc., today announce a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).
Cenduit’s IRT solution is instrumental in collecting, analyzing, and managing clinical trial data. Cenduit’s pharmaceutical, clinical research, and biotechnology customers rely on IRT solutions to effectively manage randomization and drug supply management of their clinical studies. invivodata’s ePRO solutions address the poor reliability of paper diaries by ensuring data is captured according to study protocol, resulting in enhanced speed, efficiency, and accuracy of PRO data in clinical trials.
Through this non-exclusive strategic alliance Cenduit can provide a fully integrated ePRO solution allowing key ePRO data to be fully integrated with Cenduit’s IRT offering. The combination of Cenduit’s IRT platform combined with invivodata’s EPX™ ePRO management system, supported by invivodata’s global consulting, ePRO site readiness and data management services, will provide sponsors with a uniquely integrated and streamlined approach to collecting the highest quality ePRO data in clinical trials.
“Our partner selection criteria were simple: align with the best ePRO solution provider in the global marketplace. invivodata is a proven, progressive, nimble organization with the leadership and vision to ensure healthy growth and superior delivery and customer support. The invivodata team clearly demonstrates the business disciplines and results that we value”, stated Dr. Jogin Desai, chief executive officer, Cenduit, LLC.
“By partnering with Cenduit, I am confident that we will deliver a truly unique solution to sponsors by extending and driving efficiencies in the real-world use of clinical solutions,” cites Doug Engfer, chief executive officer, invivodata, inc. “Cenduit has a compelling, forward-looking vision for creating and realizing clinical-trial efficiencies, and our organizations and solutions are aligned to deliver a powerful business-oriented approach to conducting more efficient and effective clinical research.”
About Cenduit, LLC
Cenduit is a privately owned joint venture of Quintiles and Fisher Clinical Services, part of Thermo Fisher Scientific. Cenduit has successfully deployed IRT solutions in over 650 clinical studies. Cenduit’s IRT solution is currently being used in Phase I through Phase IV clinical trials by over 16,000 sites in 78 countries, to enroll more than 220,000 subjects for over 30 indications. There are currently 46 languages utilized in the Cenduit IRT platform, supporting all languages in the ISO country list. Cenduit is dedicated to Quality, Partnership, Efficiency, and Exemplary Customer Service. Cenduit has over 200 domain specialists consisting of project management, technical, validation, programming, and quality control/assurance global staff located in Research Triangle Park, North Carolina USA, Allentown, Pennsylvania USA, Horsham, London UK, Basel, Switzerland, and Bangalore, India.
About invivodata, inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata’s solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. Invivodata, inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, California, USA.
